Detected ·
Golgenia Srl
——
Golgenia Srl, an oncology biotech developing a novel approach to reverse tumor resistance to chemotherapy, has completed its seed round with Creadd Ventures as Lead Investor, joined by Indaco Venture Partners SGR and Ruby Direct Opportunity Fund SCSP.
- Website
- —
- —
- Amount
- —
- Stage
- —
- Event
- Funding round
- Detected
- 2026-08-11 16:05:11 UTC
- Signal ID
- 1fe48cf9-abb8-4814-8132-7a5ddf2e2d69
As the API returns it
{
"id": "1fe48cf9-abb8-4814-8132-7a5ddf2e2d69",
"created_at": "2026-08-11T16:05:11.671615Z",
"company_name": "Golgenia Srl",
"company_website_url": null,
"company_linkedin_url": null,
"event_type": "funding",
"funding_amount": null,
"funding_currency": null,
"funding_stage": null,
"message": "*Golgenia Srl, an oncology biotech developing a novel approach to reverse tumor resistance to chemotherapy, has completed its seed round with Creadd Ventures as Lead Investor, joined by Indaco Venture Partners SGR and Ruby Direct Opportunity Fund SCSP.*"
}